OUTCOMES OF CORONARY ARTERY STENTING IN ELDERLY PEOPLE WITH CHRONIC HEART FAILURE

Authors

  • AGABABYAN Irina Rubenovna
  • YARASHEVA Zarrina Khikmatillaevna

Keywords:

percutaneous coronary intervention, natriuretic peptide, chronic heart failure, left ventricular ejection fraction, ischemic heart disease, coronary artery bypass grafting

Abstract

Objective: To evaluate the benefits of percutaneous coronary intervention (PCI) in reducing NT- proBNP levels and increasing left ventricular ejection fraction in elderly patients.

Methods: based on the data of the regional branch of the Republican Specialized Cardiology Scientific and Practical Medical Center of the Samarkand region, elderly patients who underwent PCI in the period from September 1 to March 1, 2022 were analyzed. A total of 80 patients were analyzed, in whom interventional intervention (IT) was performed from the radial approach in 58.75% (n=74) and from other approaches in 3.68% (n=6). Men 68.1% (n=43), women 31.9% (n=37). The mean age was 63.46 years.

Results. The study showed that in elderly people diagnosed with coronary artery disease, the following were detected: post-infarction cardiosclerosis (PICS) - 40% (n=32), 42.5% (n=34) with myocardial infarction, angina pectoris FS 3 - 17.5% ( n=14). As can be seen from diagram 2, the curved branch is most often damaged, in 40 patients the average damage rate is 80%, damage to the anterior interventricular septum (AVS) - 20 (25%), while the average damage rate is 70%, in 14 patients the damage to the right of the coronary artery (PCA), which is 70% of the average level, in 49 patients the defeat of the peripheral branches (PBV), which is 69%, of the diagonal branches. (DV) was observed in 2 patients and amounted to 78%, in whom stenting of the coronary arteries was performed, the levels of LV EF, E/e' and NTproBNP were significantly increased.

Conclusion. Currently, interventional surgery, including coronary artery stenting, balloon angioplasty and coronary artery bypass grafting, is in the first place in the treatment of patients with coronary heart disease. At the same time, a more careful approach should be taken to comorbid patients, taking into account the age of patients with chronic heart failure, for whom it is important to study the level of natriuretic peptide, as well as long-term monitoring of treatment results.

References

Adams KF Jr., Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209–16

Agababyan, I. R., & AA, R. (2019). Тhe diagnostic value of routine research methods electrocardiography and echocardiography in patients with chronic heart failure elderly. In International Conference «Process Management and Scientific Developments (pp. 168-171).

Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998;97:282–9.

Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985;312:1665–71.

Velazquez EJ, Lee KL, Deja MA, et al. Coronaryartery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364: 1607–16.

Daubert MA, Massaro J, Liao L, et al. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. Am Heart J 2015;170:550–8.

Lewis GF, Harless AC, Vazquez L, et al. Natural history and implantable cardioverter- defibrillator implantation after revascularization for stable coronary artery disease with depressed ejection fraction. Clin Cardiol 2015;38:715–9.

Russo JJ, Prasad M, Doshi D, et al. Improvement in left ventricular function following higher- risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. Catheter Cardiovasc Interv 2020;96: 764–70.

J.A. Rizaev, I.R.Agababyan, Y.A.Ismoilova ACTIVITIES OF CLINICS SPECIALIZING IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART DISEASE IN THE WORLD (REFERENCES). Journal of Biomedicine and Practice. 2021, vol. 6, issue 6, pp. 184-191

Агабабян И. Р., Ярашева З. Х., Насретдинова М. Т. Значение эхокардиографии в выявлении ранней хронической сердечной недостаточности у пациентов пожилого возраста. https://doi.org/10.34883/PI.2022.14.3.006

Ярашева З. Х. Эхокардиографическиезначения в выявлении ранней хронической сердечной недостаточности у больных пожилого возраста перенесших чрескожное коронарное вмешательство //BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – С. 124-128.

Published

2023-05-28